CSAP News

Dr. Takeo Toyoshima Reflects on Year as Board Chair

This past year has been a truly inspiring one. I learned tremendously from the other Board Members, the Government Affairs Committee members, and the intense and thought-provoking discussions had at the respective meetings. It has been eye-opening to learn about

Read More »

Prescribing

The work continues. CSAP is working in tandem with the American Psychiatric Association (APA) to address prescribing issues on the federal level. Congress put out a request for information on the national drug shortage and APA wants to better understand how far reaching

Read More »

APA / Fed Update 

Register for the 2023 Annual Meeting Virtual Summer Courses APA is excited to announce the start of the 2023 APA Annual Meeting Virtual Summer Courses! These courses are designed to provide you with an immersive learning experience led by leading experts covering

Read More »

Select Committee on Mental Health Crisis

The Assembly Select Committee on California’s Mental Health Crisis held its third hearing this week: Where do we go from here? You may view the agenda and SYASL staff notes from the hearing below.  AgendaSYASL Staff Notes 

Read More »

Children and Youth Behavioral Health Initiative 

May Equity Working Group Meeting Today, the California Health & Human Services Agency (CalHHS) held its Equity Working Group. You may view SYASL staff notes from the meeting here.  Upcoming Webinar  The California Health & Human Services Agency (CalHHS), in partnership with its departments,

Read More »

CARE Act 

Upcoming CARE Act Training and Technical Assistance: Eligibility in Practice on June 14 Health Management Associates (HMA) will provide a training session on Wednesday, June 14, from 9 a.m. to 10 a.m., to cover CARE Act eligibility criteria, including a review

Read More »

State and Federal Formulary News

Effective February 2023, the California Department of Public Health (CDPH) added the following antipsychotic injectables to the ADAP formulary: Aripiprazole (Abilify Maintena®), Aripiprazole (Aristada®), Olanzapine (Zyprexa Relprevv™), Paliperidone (Invega Sustenna®), Risperidone (Risperdal Consta®). The addition of these medications provides options

Read More »

Worth a Read

The looming Medicaid crisis ‘Deep in the weeds’: California counties face unknowns in launching mental illness court A mayor dusts off the old resume  California lawmaker who’s an addiction doctor has a dire warning on ‘tranq’ Marijuana use linked to

Read More »